Blueberries Medical Q2 Revenue Grows 169%, What About Net Loss?

Blueberries Medical Corp. (OTCQB: BBRRF) (CSE:BBM) (FRA:1OA) released its financial results for the quarter ended on June 30, 2022, revealing total revenue of CA$39,826, an increase of CA$25,041 (or 169%) compared to Q2 2021.

Q2 Financial Highlights

The gross profit, excluding the direct cost of production, in the extraction services is approximately 11%.

Gross profit was a loss of CA$75,475 compared to a loss of CA$88,021 in Q2 2021.

Net loss was CA$511,717 compared to net loss of CA$269,067 in Q2 2021

The company has pivoted its core business from cultivation to the extraction services, and identified a niche in export market of isolated products to the Latin America countries. To date, the company has been successful in exporting isolated products to Argentina. “Accordingly, in aligning with the company’s strategy, the company has begun to expand its commercial revenues, adding more final products and services to others companies in Colombia and …

Full story available on Benzinga.com

Blueberries Medical Q2 Revenue Grows 169%, What About Net Loss? on Benzinga